Inventor · Brookline, MA, US

Hidde L. Ploegh

29Patents
8h-index
36Co-inventors
75Inventor score

Filing activity: Nov 13, 1998 → Mar 10, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7776553B2 Screening assays and methods Emerging Cross-Sectional Technologies 58 Active
US6099730A Apparatus for treating whole blood comprising concentric cylinders defining an annulus therebetween Performing Operations; Transporting 34 Expired
US9751945B2 Sortase-modified VHH domains and uses thereof Chemistry; Metallurgy 33 Active
US10260038B2 Protein modification of living cells using sortase Chemistry; Metallurgy 26 Active
US8865479B2 Screening assays and methods Emerging Cross-Sectional Technologies 16 Active
US8940501B2 Methods for ligation and uses thereof Human Necessities 16 Active
US10471099B2 In vitro production of red blood cells with proteins comprising sortase recognition motifs Chemistry; Metallurgy 15 Active
US10081684B2 Using sortases to install click chemistry handles for protein ligation Chemistry; Metallurgy 12 Active
US10137426B2 Screening assays and methods Emerging Cross-Sectional Technologies 8 Active
US9463431B2 Screening assays and methods Emerging Cross-Sectional Technologies 7 Active
US10556024B2 18F labeling of proteins using sortases Physics 6 Active
US8835187B2 Screening assays and methods Emerging Cross-Sectional Technologies 6 Active
US11028185B2 Using sortases to install click chemistry handles for protein ligation Chemistry; Metallurgy 6 Active
US11492590B2 Protein modification of living cells using sortase Chemistry; Metallurgy 5 Active
US8772049B2 Screening assays and methods Emerging Cross-Sectional Technologies 5 Active
US8835188B2 Screening assays and methods Emerging Cross-Sectional Technologies 5 Active
US11266695B2 In vitro production of red blood cells with sortaggable proteins Chemistry; Metallurgy 4 Active
US6608030B1 Suppression of immune response via inhibition of cathepsin S Emerging Cross-Sectional Technologies 2 Expired
US10548959B2 Compositions and methods for modified dendrimer nanoparticle delivery Emerging Cross-Sectional Technologies 1 Active
US12048753B2 Labeling of antibodies Chemistry; Metallurgy 0 Active
US12331311B2 Protein modification of living cells using sortase Chemistry; Metallurgy 0 Active
US11992505B2 In vitro production of red blood cells with proteins comprising sortase recognition motifs Chemistry; Metallurgy 0 Active
US11154833B2 Screening assays and methods Emerging Cross-Sectional Technologies 0 Active
US7427591B2 Suppression of immune response via inhibition of cathepsin S Emerging Cross-Sectional Technologies 0 Expired
US12419940B2 Compositions and methods for modified dendrimer nanoparticle delivery Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.